Literature DB >> 6969146

Host immune status in uraemia. II. Serum factors and lymphocyte transformation.

E Stewart, T E Miller.   

Abstract

A model of experimentally induced uraemia has been used to study the effect of serum from uraemic rats on the immune responsiveness of thymus-derived (T) lymphocytes. Splenic lymphocytes from normal or uraemic animals responded to mitogenic stimulation with concanavalin A to a similar degree when cultured in a tissue culture medium containing the maximum non-toxic concentration of normal or uraemic serum in the culture system (3%). Serum from uraemic animals, however, had an immunosuppressive effect if the serum was first dialysed for 24 hr before being added to the tissue culture medium. When an alternative vessel was used which allowed the concentration of serum in the medium to be increased to 10%, serum from severely uraemic animals markedly suppressed the capacity of lymphocytes from normal animals to respond to Con A. Thus while serum from uraemic animals can be shown to be immunosuppressive, the results of the experiments are influenced by the conditions in vitro. The type of culture vessel and the concentration of serum in the culture medium are particularly critical determinants. It is likely that variations in laboratory procedures have contributed to the differences of opinion on the effect of serum from uraemic individuals on lymphocyte function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969146      PMCID: PMC1536920     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Mechanism of inhibition of adoptive transfer of tuberculin sensitivity in acute uremia.

Authors:  M F Johnston; R G Slavin
Journal:  J Lab Clin Med       Date:  1976-03

2.  The effect of uraemia on organ graft survival in the rat.

Authors:  R L Souhami; J Smith; J W Bradfield
Journal:  Br J Exp Pathol       Date:  1973-04

3.  Vitamin B6 deficiency in uremia and its implications for the depression of immune responses.

Authors:  H Dobbelstein; W F Körner; W Mempel; H Grosse-Wilde; H H Edel
Journal:  Kidney Int       Date:  1974-03       Impact factor: 10.612

4.  Primary immune response in cultures of spleen cells.

Authors:  J Marbrook
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321

5.  Antibiotics and immune processes.

Authors:  A Tarnawski; B Batko
Journal:  Lancet       Date:  1973-03-24       Impact factor: 79.321

6.  Macromolecular inhibitor of lymphocyte transformation in serum from patients with chronic renal failure.

Authors:  D S Nelson; J M Penrose
Journal:  Aust J Exp Biol Med Sci       Date:  1973-04

7.  Suppression of in vitro lymphocyte function by uremic toxins.

Authors:  J E Harris; D Pagé; G Posen; T Stewart
Journal:  J Urol       Date:  1972-08       Impact factor: 7.450

8.  Inhibition of lymphocyte transformation by guanidinosuccinic acid, a surplus metabolite in uremia.

Authors:  R G Slavin; C D Fitch
Journal:  Experientia       Date:  1971

9.  The effect of uremic plasma on lymphocyte transformation.

Authors:  M R Silk
Journal:  Invest Urol       Date:  1967-09

10.  Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.

Authors:  W M Newberry; J P Sanford
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

View more
  7 in total

Review 1.  Uraemia--does it affect host resistance to infectious disease?

Authors:  T E Miller
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

2.  Host immune status in uraemia III. Humoral response to selected antigens in the rat.

Authors:  J Nelson; D J Ormrod; D Wilson; T E Miller
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

3.  The immune status of uraemic children/adolescents with chronic renal failure and renal replacement therapy.

Authors:  R Drachman; M Schlesinger; H Shapira; A Drukker
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

4.  Synergism between immunosuppressive agents and uremia?

Authors:  T E Miller; D J Ormrod; D M Wilson
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

5.  Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vivo.

Authors:  S Ikemoto; M Kamizuru; N Hayahara; S Okamoto; S Wada; T Kishimoto; M Maekawa
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

6.  Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.

Authors:  S C Meuer; M Hauer; P Kurz; K H Meyer zum Büschenfelde; H Köhler
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

Review 7.  Infection in immunologically-mediated diseases: a review.

Authors:  J Cohen
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.